Prevalence and risk factors for selection of quinolone-resistant escherichia coli strains in fecal flora of patients receiving quinolone therapy

Creative Commons License

Yagci D., Yoruk F., Azap A., Memikoglu O.

Antimicrobial Agents and Chemotherapy, cilt.53, sa.3, ss.1287-1289, 2009 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 53 Sayı: 3
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1128/aac.01228-08
  • Dergi Adı: Antimicrobial Agents and Chemotherapy
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1287-1289
  • Ankara Üniversitesi Adresli: Evet

Özet

Patients taking quinolones as inpatients (n=55) or outpatients (n = 40) and newly hospitalized patients who were not on quinolone therapy (n = 41) were assessed for fecal carriage of quinolone-resistant Escherichia coli (QREC) strains before and after therapy/hospitalization. Fluoroquinolone use in the previous 6 months was found to be a risk factor for QREC carriage before therapy/hospitalization. The prevalence of QREC strains in fecal flora increased steadily with the duration of quinolone therapy. Copyright © 2009, American Society for Microbiology. All Rights Reserved.